Venus Remedies awarded its first incentive of Rs.7.50 crore under PLl scheme
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
The Convocation ceremony was organized for students skilled and certified in Ayush
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
BHL will undertake the development and supply of these molecules
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
The facility will accommodate over 1,500 employees
Patients visiting OPD sections of hospitals use their Ayushman Bharat Health Account (ABHA) to get instant tokens to save time spent in registration queues
Subscribe To Our Newsletter & Stay Updated